CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.
Abstract
CBS domains are defined as sequence motifs that occur in several different proteins in all kingdoms of life. Although thought to be regulatory, their exact functions have been unknown. However, their importance was underlined by findings that mutations in conserved residues within them cause a variety of human hereditary diseases, including (with the gene mutated in parentheses): Wolff-Parkinson-White syndrome (gamma 2 subunit of AMP-activated protein kinase); retinitis pigmentosa (IMP dehydrogenase-1); congenital myotonia, idiopathic generalized epilepsy, hypercalciuric nephrolithiasis, and classic Bartter syndrome (CLC chloride channel family members); and homocystinuria (cystathionine beta-synthase). AMP-activated protein kinase is a sensor of cellular energy status that is activated by AMP and inhibited by ATP, but the location of the regulatory nucleotide-binding sites (which are prime targets for drugs to treat obesity and diabetes) was not characterized. We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine beta-synthase bind AMP, ATP, or S-adenosyl methionine,while mutations that cause hereditary diseases impair this binding. This shows that tandem pairs of CBS domains act, in most cases, as sensors of cellular energy status and, as such, represent a newly identified class of binding domain for adenosine derivatives.
Overview
CoChat Summary
## TL;DR
This paper shows that tandem CBS domain pairs act as allosteric binding modules for adenosine-related ligands, including AMP and ATP in AMPK, ATP in IMPDH and CLC2, and SAM in cystathionine β-synthase. It also shows that disease-associated mutations in these domains weaken ligand binding and, in AMPK, impair AMP-dependent activation.
## Key findings
- For AMPKγ2, the isolated CBS1-2 pair bound 1 AMP molecule with Kd = 53 ± 5 µM, and the CBS3-4 pair bound 1 AMP molecule with Kd = 104 ± 10 µM; the full CBS1-4 construct bound 2 AMP molecules with B0.5 = 61 ± 2 µM and Hill coefficient = 2.2 ± 0.1.
- Disease mutations increased AMP binding constants for AMPKγ2 CBS constructs; for CBS1-4, B0.5 for AMP rose from 61 ± 2 µM (WT) to 158 ± 9 µM (R302Q), 725 ± 36 µM (H383R), 1,360 ± 47 µM (T400N), and 2,800 ± 220 µM (R531G).
- In recombinant α1β1γ2 AMPK heterotrimers, the A0.5 for AMP activation increased in the same order as binding defects: WT 7 ± 3 µM, L ins 9 ± 4 µM, R302Q 23 ± 6 µM, H383R 51 ± 40 µM, T400N 95 ± 32 µM, and R531G >100 µM; the paper also states the WT α1β1γ1, α1β1γ2, and α1β1γ3 complexes were stimulated 3.3-fold, 7.0-fold, and 1.5-fold by AMP, respectively.
- Other CBS-domain proteins showed the same pattern: IMPDH2 CBS domains bound 1 ATP molecule with Kd = 54 ± 6 µM, while the R224P mutation increased this to 450 ± 36 µM; full-length IMPDH2 bound ATP with B0.5 = 770 ± 50 µM and ATP stimulated IMPDH activity more than fourfold with A0.5 = 0.44 ± 0.05 mM and Hill coefficient = 1.3 ± 0.1; CLC2 CBS domains bound ATP with Kd = 1.06 ± 0.08 mM, and pathogenic mutations raised this to 10.4-fold (G715E) and 14-fold (G826D) higher; cystathionine β-synthase CBS domains bound SAM with Kd = 34 ± 2 µM, and D444N increased this 15-fold to 510 ± 70 µM.
## Methods
- The study cloned CBS-domain constructs from AMPKγ1, γ2, and γ3, IMPDH2, CLC2, and cystathionine β-synthase, expressed them mainly as GST fusions in bacteria, and introduced disease mutations by site-directed mutagenesis.
- Ligand binding was measured using radiolabeled AMP, ATP, or SAM with rapid filtration, and data were fit to single-site or Hill binding models; AMPK heterotrimers were also expressed in CCL13 cells and assayed for AMP-dependent activity after rapid or slow lysis.
- IMPDH2 enzymatic activity was measured by NADH formation at 340 nm in the presence or absence of ATP.
## Limitations
- The paper itself notes several unresolved issues: AMP activation of AMPK heterotrimers occurred at concentrations about tenfold lower than the B0.5 values for AMP binding to isolated CBS1-4 constructs; the three AMPKγ isoforms differed in AMP binding (20 µM, 53 µM, 125 µM) but the heterotrimers differed mainly in degree of stimulation rather than A0.5; and it states that further work is required to determine whether AMPK uses a mechanism similar to cAMP-dependent protein kinase.
- The text makes evident that some activation estimates are less precise because AMP could not be tested above 100 µM in heterotrimer assays, and the authors say the A0.5 values for H383R and T400N are less accurate, while no A0.5 could be obtained for R531G; this is an evidence-based limitation from the assay design.
- The study used purified domains and recombinant proteins in bacteria or cell culture, so direct in vivo physiology is not tested here; this is evident from the methods and experimental system, not explicitly stated as a limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 23 Not checked · 78 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| AMPK- γ 2 | CBS1-2 (WT) | 1 | 53 ± 5 | - | 175 ± 20 | - |”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant still bound AMP, but the K d increased 15-fold (Figure 1c and Table 1).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The K d for L ins was not significantly different from that for the WT.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 101 claims and to verify the 42 references still open.
- It may state two separate claims as one. 38
- The quote only partly states this claim. 1
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 4
“Binding of ATP by GST fusions of the isolated CBS domain pair (residues 112-232) ( a ) and full-length IMPDH2 (residues 1-514) ( b ).”
§ Methods
“The IMPDH2 constructs were polyhistidine-tagged and were purified on chelating Sepharose (Pharmacia, Chalfont St. Giles, United Kingdom) charged with 50 mM CoCl2 according to the manufacturer's instructions.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“the four tandem pairs of CBS domains in the γ subunits of AMPK provide two allosteric binding sites for AMP and ATP in the heterotrimeric complex”
§ Introduction
“the three γ subunit isoforms of AMPK, and their homologues in lower eukaryotes, are unique among eukaryotic proteins in having four tandem domains”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 3
“For the constructs from γ 1, γ 2, and γ 3, the B0.5 values for AMP were 20, 53, and 125 µ m, respectively.”
§ Methods
“| | CBS1-4 (WT) | 2 | 61 ± 2 | 2.2 ± 0.1 | 257 ± 14 | 2.2 ± 0.2 |”
Citations
Cites
1 retracted
Haug, K., Warnstedt, M., Alekov, A. K., Sander, T., Ramírez, A., Poser, B., Maljevic, S., Hebeisen, S., Kubisch, C., Rebstock, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1121 · Cited by 294
RetractedThe Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“It is also activated by the antidiabetic drugs metformin and rosiglitazone (21–23), and by the adipocyte-derived hormones leptin and adiponectin (24, 25).”
BackgroundCorton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Self-citationFryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
Self-citation
Research works printed but not linked: 4
- Winder, 1996, Am. J. Physiol., 270, E299
- Merrill, 1997, Am. J. Physiol., 273, E1107
- Winder, 1999, Am. J. Physiol., 277, E1
- Hardie, 2000, Methods Mol. Biol., 99, 63
Cited by
Items 201–300 of 752
Nucleotides, Nucleosides, and Nucleobases
Jensen, K. F., Dandanell, G., Hove‐Jensen, B., & Willemoës, M. (2008) · EcoSal Plus · doi:10.1128/ecosalplus.3.6.2 · Cited by 86
Characterization of the AMP-activated protein kinase pathway in chickens
Proszkowiec‐Weglarz, M., Richards, M. P., Ramachandran, R., & McMurtry, J. P. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2005.10.009 · Cited by 111
Structure and function of AMP‐activated protein kinase
Oakhill, J. S., Scott, J. W., & Kemp, B. E. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01977.x · Cited by 83
Self-citationCostford, S. R., Kavaslar, N., Ahituv, N., Chaudhry, S. N., Schackwitz, W. S., Dent, R., Pennacchio, L. A., McPherson, R., & Harper, M.-E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000903 · Cited by 85
Ruiz, A., Xu, X., & Carlson, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102758108 · Cited by 106
Servant, P., Coq, D. L., & Aymerich, S. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04473.x · Cited by 89
AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2
Fogarty, S., Ross, F. A., Vara‐Ciruelos, D., Gray, A., Gowans, G. J., & Hardie, D. G. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0479 · Cited by 99
Self-citationJęśko, H., Stępień, A., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1286-3 · Cited by 85
Mutations affecting GABAergic signaling in seizures and epilepsy
Galanopoulou, A. S. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0816-2 · Cited by 95
Kim, M., Hunter, R. W., Garcia-Menendez, L., Gong, G., Yang, Y.-Y., Kolwicz, S. C., Xu, J., Sakamoto, K., Wang, W., & Tian, R. (2014) · Circulation Research · doi:10.1161/circresaha.114.302364 · Cited by 83
Autotrophic Carbon Dioxide Assimilation in Thermoproteales Revisited
Ramos-Vera, W. H., Berg, I. A., & Fuchs, G. (2009) · Journal of Bacteriology · doi:10.1128/jb.00145-09 · Cited by 83
Weisová, P., Dávila, D., Tuffy, L. P., Ward, M. W., Concannon, C. G., & Prehn, J. H. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3544 · Cited by 88
Implication of CcpN in the regulation of a novel untranslated RNA (SR1) in Bacillus subtilis
Licht, A., Preis, S., & Brantl, S. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04810.x · Cited by 82
AMP-Activated Kinase AMPK Is Expressed in Boar Spermatozoa and Regulates Motility
de Llera, A. H., Martín‐Hidalgo, D., Gil, M. C., García, L. J., & Bragado, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038840 · Cited by 93
Targeting AMPK for cardiac protection: Opportunities and challenges
Kim, M., & Tian, R. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.004 · Cited by 87
Marković, S., & Dutzler, R. (2007) · Structure · doi:10.1016/j.str.2007.04.013 · Cited by 82
The role of AMP-activated protein kinase in the cardiovascular system
Nagata, D., & Hirata, Y. (2009) · Hypertension Research · doi:10.1038/hr.2009.187 · Cited by 86
Davies, J. K., Wells, D. J., Liu, K., Whitrow, H. R., Daniel, T. D., Grignani, R., Lygate, C. A., Schneider, J. E., Noël, G., Watkins, H., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01020.2005 · Cited by 80
Perivascular fat, AMP‐activated protein kinase and vascular diseases
Almabrouk, T. A. M., Ewart, M. A., Salt, I. P., & Kennedy, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12479 · Cited by 80
The ClC family of chloride channels and transporters
Dutzler, R. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.06.002 · Cited by 79
Pedersen, T. H., Riisager, A., de Paoli, F. V., Chen, T., & Nielsen, O. B. (2016) · The Journal of General Physiology · doi:10.1085/jgp.201611582 · Cited by 89
Mortimer, S. E., & Hedstrom, L. (2005) · Biochemical Journal · doi:10.1042/bj20042051 · Cited by 78
Human Cystathionine β-Synthase Is a Target for Sumoylation
Kabil, Ö., Zhou, Y., & Banerjee, R. V. (2006) · Biochemistry · doi:10.1021/bi0615644 · Cited by 77
Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Kemp, B. E. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-005 · Cited by 77
Gissot, L., Polge, C., Jossier, M., Girin, T., Bouly, J., Kreis, M. E., & Thomas, M. (2006) · PLANT PHYSIOLOGY · doi:10.1104/pp.106.087718 · Cited by 93
Protein surface analysis for function annotation in high‐throughput structural genomics pipeline
Binkowski, T. A., Joachimiak, A., & Liang, J. (2005) · Protein Science · doi:10.1110/ps.051759005 · Cited by 75
Cao, Y., Bojjireddy, N., Kim, M., Li, T., Zhai, P., Nagarajan, N., Sadoshima, J., Palmiter, R. D., & Tian, R. (2017) · Circulation Research · doi:10.1161/circresaha.117.311159 · Cited by 74
Thomas, E. C., Gunter, J. H., Webster, J. A., Schieber, N. L., Oorschot, V. M. J., Parton, R. G., & Whitehead, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051096 · Cited by 78
Regulated proteolysis in bacterial development
Konovalova, A., Søgaard‐Andersen, L., & Kroos, L. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12050 · Cited by 88
AMP-activated protein kinase: Structure, function, and role in pathological processes
Novikova, D., Garabadzhiu, A. V., Melino, G., Barlev, N. A., & Tribulovich, V. G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915020017 · Cited by 84
Dokladda, K., Green, K. A., Pan, D. A., & Hardie, D. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.084 · Cited by 75
Self-citationMount, P. F., Hill, R., Fraser, S. A., Levidiotis, V., Katsis, F., Kemp, B. E., & Power, D. A. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00458.2004 · Cited by 82
Saint-Martin, C., Gauvain, G., Teodorescu, G., Gourfinkel‐An, I., Fédirko, E., Weber, Y. G., Maljevic, S., Ernst, J., García‐Olivares, J., Fahlke, C. M., et al. (2009) · Human Mutation · doi:10.1002/humu.20876 · Cited by 73
Garcia-Haro, L., Garcia-Gimeno, M. A., Neumann, D., Beullens, M., Bollen, M., & Sanz, P. (2010) · The FASEB Journal · doi:10.1096/fj.10-166306 · Cited by 73
Zhang, M., Wu, J., Sun, R., Tao, X., Wang, X., Kang, Q., Wang, H., Zhang, L., Liu, P., Zhang, J., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0211796 · Cited by 72
Purification and characterization of the three Snf1-activating kinases of Saccharomyces cerevisiae
Elbing, K., McCartney, R. R., & Schmidt, M. C. (2006) · Biochemical Journal · doi:10.1042/bj20051213 · Cited by 72
Hanyu, Y., Imai, K. K., Kawasaki, Y., Nakamura, T., Nakaseko, Y., Nagao, K., Kokubu, A., Ebe, M., Fujisawa, A., Hayashi, T., et al. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01290.x · Cited by 70
Properties of an unusual heme cofactor in PLP-dependent cystathionine β-synthase
Singh, S., Madzelan, P., & Banerjee, R. (2007) · Nat. Prod. Rep. · doi:10.1039/b604182p · Cited by 70
Fraser, S. A., Mount, P. F., Hill, R., Levidiotis, V., Katsis, F., Stapleton, D., Kemp, B. E., & Power, D. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00190.2004 · Cited by 74
Tadié, J., Bae, H., Deshane, J. S., Bell, C. P., Lazarowski, E. R., Chaplin, D., Thannickal, V. J., Abraham, E. H., & Zmijewski, J. W. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00401 · Cited by 72
SAMARI, H. R., MØLLER, M. T. N., HOLDEN, L., ASMYHR, T., & SEGLEN, P. O. (2005) · Biochemical Journal · doi:10.1042/bj20040609 · Cited by 58
Schmeling, S., Narmandakh, A., Schmitt, O., Gad’on, N., Schühle, K., & Fuchs, G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.23.8044-8057.2004 · Cited by 69
AMPK Structure and Regulation from Three Angles
Kemp, B. E., Oakhill, J. S., & Scott, J. W. (2007) · Structure · doi:10.1016/j.str.2007.09.006 · Cited by 69
Self-citationSerotonin and Dopamine Protect from Hypothermia/Rewarming Damage through the CBS/ H2S Pathway
Talaei, F., Bouma, H. R., van der Graaf, A. C., Strijkstra, A. M., Schmidt, M., & Henning, R. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022568 · Cited by 70
Rajamohan, F., Reyes, A. R., Frisbie, R. K., Hoth, L. R., Sahasrabudhe, P., Magyar, R., Landro, J. A., Withka, J. M., Caspers, N. L., Calabrese, M. F., et al. (2016) · Biochemical Journal · doi:10.1042/bj20151051 · Cited by 67
The CBS subdomain of inosine 5′‐monophosphate dehydrogenase regulates purine nucleotide turnover
Pimkin, M., & Markham, G. D. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06153.x · Cited by 69
Akman, H. O., Sampayo, J. N., Ross, F. A., Scott, J. W., Wilson, G. J., Benson, L. N., Bruno, C., Shanske, S., Hardie, D. G., & DiMauro, S. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3181462b86 · Cited by 70
Self-citationAmato, S., & Man, H. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17953 · Cited by 82
Bokko, P. B., Francione, L., Bandala-Sanchez, E., Ahmed, A. U., Annesley, S. J., Huang, X., Khurana, T., Kimmel, A. R., & Fisher, P. R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0881 · Cited by 67
Multiple Motif Scanning to Identify Methyltransferases from the Yeast Proteome
Petrossian, T. C., & Clarke, S. G. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900025-mcp200 · Cited by 76
Weeks, C. L., Singh, S., Madzelan, P., Banerjee, R. V., & Spiro, T. G. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904468w · Cited by 65
Gunter, J. H., Thomas, E. C., Lengefeld, N., Krüger, S., Worton, L. E., Gardiner, E. M., Jones, A., Barnett, N. L., & Whitehead, J. P. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.12.018 · Cited by 65
Jehuda, R. B., Eisen, B., Shemer, Y., Mekies, L. N., Szántai, Á., Reiter, I., Cui, H., Guan, K., Haron‐Khun, S., Freimark, D., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.09.024 · Cited by 68
Gregor, M., Zeöld, A., Oehler, S., Marobela, K. A., Fuchs, P., Weigel, G., Hardie, D. G., & Wiche, G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02891 · Cited by 63
Self-citationDirect AMP-activated protein kinase activators: a review of evidence from the patent literature
Giordanetto, F., & Karis, D. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.743994 · Cited by 63
Identification and characterization
Bernstein, J., & Reutzel‐Edens, S. M. (2019) · urn:isbn:978-1-118-41628-0 · Cited by 112
Majtán, T., Singh, L. R., Wang, L., Kruger, W. D., & Kraus, J. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805928200 · Cited by 67
Walton, E. F., Wu, R., Richardson, A. C., Davy, M. W., Hellens, R. P., Thodey, K., Janssen, B. J., Gleave, A. P., Rae, G. M., Wood, M., et al. (2009) · Journal of Experimental Botany · doi:10.1093/jxb/erp231 · Cited by 65
Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon
Gianesello, L., Prete, D. D., Anglani, F., & Calò, L. A. (2020) · Human Genetics · doi:10.1007/s00439-020-02219-2 · Cited by 62
Ross, F. A., Rafferty, J. N., Dallas, M. L., Ogunbayo, O., Ikematsu, N., McClafferty, H., Tian, L., Widmer, H., Rowe, I. C. M., Wyatt, C. N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189779 · Cited by 62
Self-citationActivation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβ
Iseli, T. J., Turner, N. A., Zeng, X., Cooney, G. J., Kraegen, E. W., Yao, S., Ye, Y., James, D. E., & Ye, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062309 · Cited by 66
Jung, K., Cao, P., Seo, Y., Dardick, C. D., & Ronald, P. C. (2010) · Trends in Plant Science · doi:10.1016/j.tplants.2010.08.004 · Cited by 61
Fogarty, S., & Hardie, D. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806152200 · Cited by 61
Self-citationMammalian γ2 AMPK regulates intrinsic heart rate
Yavari, A., Bellahcene, M., Bucchi, A., Sirenko, S., Pintér, K., Herring, N., Jung, J., Tarasov, K. V., Sharpe, E. J., Wolfien, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01342-5 · Cited by 64
Stanley, D. N., Raines, C. A., & Kerfeld, C. A. (2012) · PLANT PHYSIOLOGY · doi:10.1104/pp.112.210542 · Cited by 67
Steenbergen, S. M., Lee, Y., Vann, W. F., Vionnet, J. A., Wright, L. F., & Vimr, E. R. (2006) · Journal of Bacteriology · doi:10.1128/jb.00466-06 · Cited by 60
AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals
Chung, M., Choi, H., & Hwang, J. (2021) · Nutrients · doi:10.3390/nu13114050 · Cited by 69
Singh, S., Madzelan, P., Stasser, J. P., Weeks, C. L., Becker, D., Spiro, T. G., Penner‐Hahn, J. E., & Banerjee, R. V. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.01.009 · Cited by 64
Quinn, J. M. W., Tam, S., Sims, N. A., Saleh, H., McGregor, N. E., Poulton, I. J., Scott, J. W., Gillespie, M. T., Kemp, B. E., & van Denderen, B. J. W. (2010) · The FASEB Journal · doi:10.1096/fj.09-137158 · Cited by 57
Self-citationMoreno-Andrés, D., Towler, M. C., Hardie, D. G., Knecht, E., & Sanz, P. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0227 · Cited by 68
Self-citationIMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
Pua, K. H., Stiles, D. T., Sowa, M. E., & Verdine, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.030 · Cited by 56
Buey, R. M., Fernández‐Justel, D., Marcos‐Alcalde, Í., Winter, G., Gómez‐Puertas, P., de Pereda, J. M., & Revuelta, J. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-02805-x · Cited by 57
Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing
Gu, X., Yan, Y., Novick, S. J., Kovach, A., Goswami, D., Ke, J., Tan, M. H., Wang, L., Li, X., de Waal, P. W., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793018 · Cited by 65
Nilsson, E. C., Long, Y. C., Martinsson, S., Glund, S., Garcia-Roves, P., Svensson, L. T., Andersson, L., Zierath, J. R., & Mahlapuu, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510461200 · Cited by 58
AMP-Activated Protein Kinase: Do We Need Activators or Inhibitors to Treat or Prevent Cancer?
Russell, F. M., & Hardie, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010186 · Cited by 59
Self-citationRecent advances in anti-inflammation via AMPK activation
Xu, Y., Bai, L., Yang, X., Huang, J.-L., Wang, J., Wu, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33670 · Cited by 84
IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNA
Mortimer, S. E., Xu, D. L., McGrew, D. A., Hamaguchi, N., Lim, H. C., Bowne, S. J., Daiger, S. P., & Hedstrom, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806143200 · Cited by 60
Biochemical and structural insights into intramembrane metalloprotease mechanisms
Kroos, L., & Akiyama, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.03.032 · Cited by 58
Recent advances in understanding the clinical and genetic heterogeneity of Dent's disease
Ludwig, M. Z., Utsch, B., & Monnens, L. A. H. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl346 · Cited by 58
Sensory Perception in Bacterial Cyclic Diguanylate Signal Transduction
Randall, T. E., Eckartt, K. N., Kakumanu, S., Price‐Whelan, A., Dietrich, L. E. P., & Harrison, J. J. (2021) · Journal of Bacteriology · doi:10.1128/jb.00433-21 · Cited by 66
Foretz, M., Taleux, N., Guigas, B., Horman, S., Beauloye, C., Andreelli, F., Bertrand, L., & Viollet, B. (2006) · médecine/sciences · doi:10.1051/medsci/2006224381 · Cited by 56
A structural perspective on ClC channel and transporter function
Dutzler, R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.016 · Cited by 56
Chen, L., Ge, X., Dou, Y., Wang, X., Patel, J. R., & Xu, P. (2010) · Microbiology · doi:10.1099/mic.0.039669-0 · Cited by 56
Shah, S. Z. A., Zhao, D., Hussain, T., & Yang, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.004 · Cited by 55
“These findings are consistent with a previous study reporting that isolated γ2 subunits of AMPK bound to two adenine nucleotide molecules (Scott et al., 2004).”
ResultAMPK Localization: A Key to Differential Energy Regulation
Afinanisa, Q., Cho, M., & Seong, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010921 · Cited by 63
Hancock, C. R., Janssen, E., & Terjung, R. L. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00885.2005 · Cited by 55
Cadmium Exposure Alters Metabolomics of Sulfur-Containing Amino Acids in Rat Testes
Sugiura, Y., Kashiba, M., Maruyama, K., Hoshikawa, K., Sasaki, R., Saito, K., Kimura, H., Goda, N., & Suematsu, M. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.781 · Cited by 55
Spasić, M. R., Callaerts, P., & Norga, K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1646-08.2008 · Cited by 60
SNP variation in the promoter of the PRKAG3gene and association with meat quality traits in pig
Ryan, M. T., Hamill, R. M., O’Halloran, A. M., Davey, G. C., McBryan, J., Mullen, A. M., McGee, C., Gispert, M., Southwood, O. I., & Sweeney, T. (2012) · BMC Genetics · doi:10.1186/1471-2156-13-66 · Cited by 66
Intracellular regulation of human ClC‐5 by adenine nucleotides
Zifarelli, G., & Pusch, M. (2009) · EMBO Reports · doi:10.1038/embor.2009.159 · Cited by 55
Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity
Siggs, O. M., Stockenhuber, A., Deobagkar‐Lele, M., Bull, K. R., Crockford, T. L., Kingston, B. L., Crawford, G., Anzilotti, C., Steeples, V., Ghaffari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607592113 · Cited by 62
Yang, X., Wang, H., Huang, C. S., He, X., Xu, W., Luo, Y., & Huang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14868-x · Cited by 61
Dai, Y., Amenov, A., Ignatyeva, N., Koschinski, A., Xu, H., Soong, P. L., Tiburcy, M., Linke, W. A., Zaccolo, M., Hasenfuss, G. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56597-3 · Cited by 58
Hardie, D. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010819 · Cited by 55
Self-citationEvande, R., Ojha, S., & Banerjee, R. V. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.027 · Cited by 54
Ludwig, M. Z., Doroszewicz, J., Seyberth, H. W., Bökenkamp, A., Balluch, B., Nuutinen, M., Utsch, B., & Waldegger, S. (2005) · Human Genetics · doi:10.1007/s00439-005-1303-2 · Cited by 58
Linkage and mutational analysis of CLCN2 in childhood absence epilepsy
Everett, K. V., Chioza, B. A., Aicardi, J. F., Aschauer, H. N., Brouwer, O. F., Callenbach, P. M. C., Covanis, A., Dooley, J. M., Dulac, O., Durner, M., et al. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.05.004 · Cited by 54
Molecular Cell Biology and Immunobiology of Mammalian Rod/Ring Structures
Carcamo, W. C., Calise, S. J., von Mühlen, C. A., Satoh, M., & Chan, E. K. L. (2014) · International review of cytology · doi:10.1016/b978-0-12-800097-7.00002-6 · Cited by 52
Lucas, M., Encinar, J. A., Astigarraga, E., Oyenarte, I., García, I. G., Kortázar, D., Fernández, J. A., Mato, J. M., Martínez‐Chantar, M. L., & Martínez‐Cruz, L. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.12.012 · Cited by 52
Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK
Mount, P. F., Lane, N., Venkatesan, S., Steinberg, G. R., Fraser, S. A., Kemp, B. E., & Power, D. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.003 · Cited by 55
Metadata
- Authors
- Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., & Hardie, D. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2004-01-15
- Volume
- 113
- Issue
- 2
- Pages
- 274-284
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC311435
- OpenAlex
- W2166714586
- Cited by
- 754
- References
- 56
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 19 · 2023: 16 · 2022: 18 · 2021: 19 · 2020: 19 · 2019: 23 · 2018: 27 · 2017: 37 · 2016: 25 · 2015: 22 · 2014: 33 · 2013: 35 · 2012: 59
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (QLG1-CT-2001-01488)
- European Commission
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- CBS domain, energy sensing, AMPK, cystathionine beta-synthase, S-adenosylmethionine, pathogenic variants, genetic disorders, nucleotide binding site
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Allosteric Site, Animals, Binding Sites, Cloning, Molecular, DNA, Dose-Response Relationship, Drug, Escherichia coli, Glutathione Transferase, Humans, Kinetics, Ligands, Liver, Models, Molecular, Mutation, Plasmids, Protein Binding, Recombinant Fusion Proteins, Recombinant Proteins, Retinitis Pigmentosa, Polymerase Chain Reaction, Protein Structure, Tertiary, DNA, Complementary, Dimerization, Protein Isoforms, Amino Acid Motifs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.